Major European stock indexes moved higher on Tuesday, buoyed by upbeat corporate earnings and easing fears of a full-blown trade conflict.

Investor sentiment remained cautious, however, as the euro weakened following mixed reactions among EU leaders to a recent trade agreement with the United States. Market participants are also closely monitoring U.S.-China talks taking place in Sweden, where negotiators aim to extend a temporary pause in tariff hikes.

In afternoon trading, France’s CAC 40 gained 1.2%, Germany’s DAX rose 1.1%, and London’s FTSE 100 edged up 0.5%.

Among individual movers, Swiss engineering group ABB (TG:ABB) advanced roughly 1% after landing a contract to support Tata Steel’s decarbonization initiative at its Port Talbot facility in the UK.

Shares of Tobii AB (TG:24T) tumbled 16%. Despite strong Q2 results, the eye-tracking technology firm disappointed investors with forward guidance.

AstraZeneca (LSE:AZN) rose 2.2% in London following second-quarter earnings that came in ahead of forecasts.

Essentra (LSE:ESNT) surged 6% after the manufacturer reaffirmed its full-year outlook and delivered first-half results in line with market projections.

TeamViewer SE (TG:TMV) gained more than 5% as the German software provider reiterated its annual revenue guidance on the back of improved H1 earnings.

In contrast, Stellantis NV (BIT:STLAM) fell 2.4% after reporting a net loss of €2.3 billion ($2.65 billion) for the first half of the year.

Dutch medtech firm Philips (EU:PHIA) jumped 10% after raising its profitability forecast.

Air Liquide (EU:AI) rose 2.6% as the French industrial gas company maintained its margin outlook through 2026 and posted half-year sales in line with analyst expectations.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.